[PDF][PDF] di Indonesia

P Covid - Retrieved Februari, 19 - konsumen-cerdas.s3.ap-southeast-1 …
Puji dan syukur kami panjatkan kehadirat Tuhan Yang Maha Esa atas berkat dan karunia-
Nya sehingga BPOM dapat menyelesaikan penyusunan Informatorium Obat COVID-19 di …

Human umbilical cord mesenchymal stromal cell treatment of severe COVID-19 patients: a 3-month follow-up study following hospital discharge

G Feng, L Shi, T Huang, N Ji, Y Zheng… - Stem Cells and …, 2021 - liebertpub.com
Previously, we demonstrated the therapeutic effects of human umbilical cord mesenchymal
stromal cells (hUC-MSCs) in severe coronavirus disease 2019 (COVID-19) patients. In this 3 …

Human placenta/umbilical cord derivatives in regenerative medicine–Prospects and challenges

A Biswas, R Rajasekaran, B Saha, K Dixit… - Biomaterials …, 2023 - pubs.rsc.org
The human placenta and umbilical cord, natural birth biowaste, are a housing unit for
numerous bioactive macromolecules, growth factors, collagen and GAGs, with an array of …

Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial

ME Martínez-Muñoz, C Payares-Herrera… - Bone Marrow …, 2024 - nature.com
Mesenchymal stromal cells (MSC) have immunomodulatory and tissue-regenerative
properties and have shown promising results in acute respiratory distress syndrome (ARDS) …

Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge

MS Winkler, T Skirecki, FM Brunkhorst, S Cajander… - …, 2021 - thelancet.com
Many milestones in medical history rest on animal modeling of human diseases. The SARS-
CoV-2 pandemic has evoked a tremendous investigative effort primarily centered on clinical …

[HTML][HTML] Bio-distribution and longevity of mesenchymal stromal cell derived membrane particles

J Vos, H Tejeda-Mora, A Merino, L Wu… - Journal of Controlled …, 2022 - Elsevier
Vesicle-based medicines hold great promise for therapy development but essential
knowledge on the bio-distribution and longevity of vesicles after administration is lacking …

Stem cells therapy for COVID-19: a systematic review and meta-analysis

E Arabpour, S Khoshdel, N Tabatabaie… - Frontiers in …, 2021 - frontiersin.org
Introduction: Vaccination seems to be a good solution for preventing and controlling
coronavirus disease (COVID-19) pandemic, but still there are some challenges in COVID-19 …

Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis

C Yang, R Chen, Q Zhu, S Han, M Kuang - Frontiers in Immunology, 2022 - frontiersin.org
Objectives A major challenge for COVID-19 therapy is dysregulated immune response
associated with the disease. Umbilical cord mesenchymal stromal cells (UC-MSCs) may be …

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review

B Sadeghi, O Ringdén, B Gustafsson… - Frontiers in …, 2022 - frontiersin.org
Acute respiratory distress syndrome (ARDS) is a life-threatening lung disease. It may occur
during the pancytopenia phase following allogeneic hematopoietic cell transplantation …

Immune response to COVID-19 infection: a double-edged sword

N Saad, S Moussa - Immunological medicine, 2021 - Taylor & Francis
COVID-19 global pandemic has not ceased to spread worldwide since December 2019.
Today, scientists and healthcare workers are urgently working to stop this viral invasion and …